Downregulation of long non-coding RNAs in patients with bipolar disorder

Sci Rep. 2022 May 6;12(1):7479. doi: 10.1038/s41598-022-11674-y.

Abstract

The abnormal function of signaling cascades is currently a candidate in the pathophysiology of bipolar disorder (BD). One of the factors involved in activating these signals is oxidative stress. Some long non-coding RNAs (lncRNA) are involved in the oxidative stress. In this study, we compared expression levels of lincRNA-p21, lincRNA-ROR, and lincRNA-PINT in the peripheral blood mononuclear cells (PBMC) from BD patients (n = 50) and healthy individuals (n = 50). Expression levels of lincRNA-p21, lincRNA-ROR, and lincRNA-PINT were significantly reduced in patients with BD compared to controls. In sex-based analyses, down-regulation of these lncRNAs was revealed only in male BD patients compared to male healthy subjects. Also, in BD patients, all three lncRNAs showed a significant pairwise positive correlation in expression level. The area under curve values for lincRNA-p21, lincRNA-ROR, and lincRNA-PINT was 0.66, 0.75, and 0.66, respectively. Thus, the ROC curve analysis showed that lncRNA-ROR might serve as a diagnostic biomarker for distinguishing between BD patients and controls. Altogether, the current study proposes a role for lincRNA-p21, lincRNA-ROR, and lincRNA-PINT in the pathogenesis of bipolar disorder. Moreover, the peripheral expression of these lncRNAs might be useful as potential biomarkers for BD.

MeSH terms

  • Area Under Curve
  • Bipolar Disorder* / genetics
  • Bipolar Disorder* / metabolism
  • Down-Regulation / genetics
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • Male
  • RNA, Long Noncoding* / genetics

Substances

  • Linc-RNA-RoR, human
  • RNA, Long Noncoding